XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (1,760,981) $ (5,202,581)
Adjustments to reconcile net loss to net cash used in operating activities:    
Unrealized (gain) loss on investment securities, net (696,965) 3,836
Realized loss on investment securities, net 7
Stock-based compensation 462,467 164,228
Accretion of investments at amortized cost (U.S Treasury Bills) (431,776)
Purchases of investment securities, at fair value (made by our licensed broker dealer) (1,587,500)
Purchases of investment securities, at cost less impairment (200,000)
Proceeds from sale of investment securities, at fair value (made by our licensed broker dealer) 632,851
Deferred income tax 225,874
Warrants issued as part of an investment banking deal 165,087
Income recognized from warrants received (2,645,620)
Depreciation of property and equipment 137,972 104,614
Accretion of deferred grant reimbursement (38,880) (32,909)
Deferred revenue 100,000
Non-cash lease expense 69,986 8,626
(Increase) decrease in -    
Grants receivable 133,080 (370,516)
Prepaid expenses and other current assets (251,718) (813)
Increase (decrease) in -    
Accounts payable 341,348 38,308
Income taxes payable 158,269
Accrued expenses (100,481) 471,814
Deferred grant reimbursement (22,455) 80,410
Net cash used in operating activities (5,109,442) (4,934,976)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds of investments securities, at amortized cost (U.S Treasury Bills) 15,078,020
Purchases of investments securities, at amortized cost (U.S Treasury Bills) (5,953,312) (11,061,058)
Purchases of property and equipment (355,634) (162,416)
Net cash provided by (used in) investing activities 8,769,074 (11,223,474)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from private placement 25,289,660
Proceeds from initial public offering 19,999,992
Costs of private placement (436,578)
Costs from initial public offering (2,166,698)  
Deferred costs of initial public offering (480,578)
Distribution to member (2,723,700)
Acquisition of non-controlling interest in PatentVest (125,000)
Net cash provided by financing activities 17,833,294 21,523,804
NET INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH 21,492,926 5,365,354
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH - BEGINNING OF PERIOD 4,952,624 6,225,458
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH - END OF PERIOD 26,445,550 11,590,812
Supplemental disclosures of cash flow information:    
Interest 9
Income taxes
Non-cash investing and financing activities:    
Distribution of equity to members and subsequent contribution into MDB Capital Holdings, LLC - Invizyne and PatentVest 661,799
Ownership change of non-controlling interest 436,894
Partner contribution of members equity into MDB Capital Holdings, LLC 6,049,225
Warrants received as part of an investment banking deal 2,480,533
Modification of lease - right-of-use asset and lease liability 198,544
Record right-of-use asset and operating lease liability 698,249
Relinquishment of deferred costs of initial public offering from prior year 323,224
Investment securities, at cost less impairment, received in lieu of cash payment 100,000
Issuance of Class A common shares in exchange for non-controlling interest in PatentVest 200,000
Issuance of warrants to purchase Class A stock related to the initial public offering closed on September 20, 2023 65,411
Issuance of warrants to purchase Class A stock related to the private placement offering closed on June 15, 2022 $ 106,940